A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell Carcinoma
Kidney Cancer · 2017
DOI: 10.3233/kca-160004 ↗Kurz gefasst
Fallbericht in der Zeitschrift Kidney Cancer, 2017. Verfasst von Erica Nakajima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
We report a case of severe type B lactic acidosis (LA) in a 51-year-old male, 12 days after he received his first dose of nivolumab for metastatic Von Hippel Lindau ( VHL)-mutated, clear cell renal cell carcinoma. Throughout his hospital course, infection, hypoperfusion, and tissue necrosis were not identified. We propose that his LA may have resulted from either inherent tumor glycolysis or immune activation and enhanced metabolism. The patient’s course was complicated by acute renal failure, and his LA rose progressively, eventually necessitating daily hemodialysis (HD). After receiving five consecutive days of HD, the patient started everolimus daily with the intent of reducing glycolytic metabolism. Subsequently, the rate of lactic acid production slowed, and HD was no longer required after two doses of everolimus. To our knowledge, this is the first reported case of type B LA following nivolumab administration, and the use of everolimus to treat type B LA in a patient with renal cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
- Division of Hematology and Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Nakajima, E., Leger, P., Mayer, I. A., Neuss, M. N., Chism, D. D., & Rathmell, W. K. (2017). A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell Carcinoma. Kidney Cancer. https://doi.org/10.3233/kca-160004
Vancouver
Nakajima E, Leger P, Mayer IA, Neuss MN, Chism DD, Rathmell WK. A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell Carcinoma. Kidney Cancer. 2017. doi:10.3233/kca-160004
BibTeX
@article{Nakajima2017,
author = {Nakajima, Erica and Leger, Paul and Mayer, Ingrid A and Neuss, Michael N and Chism, David D and Rathmell, W Kimryn},
title = {A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell Carcinoma},
journal = {Kidney Cancer},
year = {2017},
doi = {10.3233/kca-160004}
}
EUVIMED